Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -255,568 | -95,178 | -74,163 | -29,076 | -14,068 |
| Depreciation Amortization | 54,686 | 350 | 319 | 74 | 162 |
| Accounts receivable | -17,138 | 373 | -308 | -786 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 620 | 889 |
| Other Working Capital | -40,331 | 16,681 | -358 | -722 | 11,068 |
| Other Operating Activity | 121,269 | 4,380 | 5,846 | 1,668 | -316 |
| Operating Cash Flow | $-137,082 | $-73,394 | $-68,664 | $-28,222 | $-2,265 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -44,964 | -77,652 | N/A | N/A |
| PPE Investments | -113 | -1,018 | -557 | -27 | -31 |
| Net Acquisitions | 38,641 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -64,148 | -55,309 |
| Sale Of Investment | 50,579 | 87,851 | 66,454 | 49,085 | 17,824 |
| Investing Cash Flow | $89,107 | $41,869 | $-11,755 | $-15,090 | $-37,516 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61,949 | 14,079 | 92,374 | 34 | N/A |
| Other Financing Activity | -141 | 33,871 | 0 | 49,457 | 0 |
| Financing Cash Flow | $61,808 | $47,950 | $92,374 | $49,491 | $0 |
| Exchange Rate Effect | 1 | 41 | -43 | N/A | N/A |
| Beginning Cash Position | 44,584 | 28,118 | 16,206 | 4,027 | 43,808 |
| End Cash Position | 58,418 | 44,584 | 28,118 | 10,206 | 4,027 |
| Net Cash Flow | $13,834 | $16,466 | $11,912 | $6,179 | $-39,781 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,082 | -73,394 | -68,664 | -28,222 | -2,265 |
| Capital Expenditure | -113 | -1,058 | -567 | -27 | -31 |
| Free Cash Flow | -137,195 | -74,452 | -69,231 | -28,249 | -2,296 |